Nicholas Benedict
CEO and Co-founder, ALLECRA THERAPEUTICS
Biotechnology
Clinical Research
France
Biography
Nicholas Benedict, BA (Hons) King‘s College London University, MBA Univ. Manchester, UK. Nicholas has over 25 years’ experience in the pharma industry, starting in finance in F. Hoffmann-La Roche before moving to marketing, sales and General Management. Roles have included Global Head of Anti-infectives Business Unit at Novartis AG in Switzerland, COO of Novartis UK, Chief Commercial Officer at Basilea Pharmaceutica where he successfully co-led the company’s follow-on offering raising over CHF320 million, and CEO of Swiss start-up Lumavita AG
Research Interest
Anti-infectives
